Case report: Clinical experience of treating pembrolizumab-induced systemic capillary leak syndrome (SCLS) in one patient with metastatic gastroesophageal junction squamous cell carcinoma
Systemic capillary leak syndrome (SCLS) is a rare and complex adverse effect of immune checkpoint inhibitors (ICIs). The diagnosis of drug-induced SCLS is based on diffuse infusions of exudative fluid into the interstitial areas and the exclusion of other causes. The best management of ICIs-induced...
Saved in:
Main Authors: | Hua Ni (Author), Xinjia Ding (Author), Shikai Wu (Author), Xuan Jin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acitretin-Induced systemic capillary leak syndrome
by: Kolluri Siva Bala Vaishnavi, et al.
Published: (2023) -
Dedifferentiated Liposarcoma of the Gastroesophageal Junction
by: Gökçe AŞKAN, et al.
Published: (2018) -
Capillary Leak Syndrome From Rituximab Therapy of Lymphoma
by: Krishna Vedala MD, MPH, et al.
Published: (2020) -
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy in Metastatic Non-Squamous and Squamous NSCLC Patients With PD-L1 Expression ≥ 50%
by: Qiao Liu, et al.
Published: (2022) -
The systemic capillary leak syndrome following COVID-19 vaccine
by: Chengjie Zhao, et al.
Published: (2024)